Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-20T14:20:33.502Z Has data issue: false hasContentIssue false

Chapter 12 - Uncommon lineage-unrelated tumors

Published online by Cambridge University Press:  05 July 2016

Ophelia E. Dadzie
Affiliation:
Hillingdon Hospitals NHS Foundation Trust
Meera Mahalingam
Affiliation:
VA Consolidated Laboratories, New England
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Primary Sources

Christopherson, W.M., Foote, F.W., and Stewart, F.W. (1952). Alveolar soft-part sarcomas; structurally characteristic tumors of uncertain histogenesis. Cancer, 5, 100–11.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Lieberman, P.H., Brennan, M.F., Kimmel, M., et al. (1989). Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer, 63, 113.Google Scholar
Portera, C.A. Jr, Ho, V., Patel, S.R., et al. (2001). Alveolar soft part sarcoma. Cancer, 91, 585–91.Google Scholar
Evans, H.L. (1985). Alveolar soft-part sarcoma. A study of 13 typical examples and one with a histologically atypical component. Cancer, 55, 912–17.Google Scholar
Zarrin-Khameh, N. and Kaye, K.S. (2007). Alveolar soft part sarcoma. Arch Pathol Lab Med, 131, 488–91.CrossRefGoogle ScholarPubMed
Ordonez, N.G. and Mackay, B. (1998). Alveolar soft-part sarcoma: a review of the pathology and histogenesis. Ultrastruct Pathol, 22, 275–92.Google Scholar
Ladanyi, M., Lui, M.Y., Antonescu, C.R., et al. (2001). The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene, 20, 4857.Google Scholar
Argani, P., Lal, P., Hutchinson, B., et al. (2003). Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol, 27, 750–61.Google Scholar
Lazar, A.J., Lahat, G., Myers, S.E., et al. (2009). Validation of potential therapeutic targets in alveolar soft part sarcoma: an immunohistochemical study utilizing tissue microarray. Histopathology, 55, 750–5.CrossRefGoogle ScholarPubMed
Tsuda, M., Davis, I.J., Argani, P., et al. (2007). TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res, 67, 919–29.Google Scholar

Secondary Sources

Tallini, G. (1998). Oncocytic tumors. Virchows Arch, 433, 512.CrossRefGoogle Scholar
Chang, A, Harawi, SJ (1992). Oncocytes, oncocytosis and oncocytic tumors. Pathology Annual, 27, 263304.Google Scholar
Morgan, M.B., Truitt, C.A., Romer, C., et al. (1998). Ocular adnexal oncocytoma: a case series and clinicopathologic review of the literature. Am J Dermatopathol, 20, 487–90.Google Scholar
Biggs, S.L. and Font, R.L. (1997). Oncocytic lesions of the caruncle and other ocular adnexa. Arch Opthalmol, 95, 474–8.Google Scholar
Fukuo, Y., Takeda, N., Hirata, H., et al. (1994). Immunohistologic studies of an oncocytoma. Ophthalmologica, 208, 267–9.Google Scholar
Rodgers, I.R., Jakobiec, F.A., Kreb, W., et al. (1988). Papillary oncocytoma of the eyelid. A previously undescribed tumor of apocrine gland origin. Ophthalmology, 95, 1071–6.Google Scholar
O'Connor, S.R., Tan, J.H., Walewska, R., et al. (2002). Angiotropic lymphoma occurring in a lacrimal sac oncocytoma. J Clin Pathol, 55, 787–8.Google Scholar
Morand, B., Bettega, G., Bland, V., et al. (1998). Oncocytoma of the eyelid – an aggressive benign tumor. Ophthalmology, 105, 2220–4.Google Scholar
Coburn, V., Radfar, A., Snook, D., et al. (2007). Cutaneous oncocytoma – a report of three cases and review of the literature. J Cutan Pathol, 34, 355–9.CrossRefGoogle ScholarPubMed
Van Roogen, J.F.G. and Fletcher, C.D.M. (1999). Myxoid tumors of soft tissue. Histopathology, 35, 291312.Google Scholar
Ireland, D.C.R. (1973). Myxoma of somatic soft tissues: a report of 58 patients, 3 with multiple tumors and fibrous dysplasia of bone. Mayo Clin Proc, 48, 401–10.Google Scholar
Lisovsky, M., Hoang, M.P., Dresser, K., et al. (2008). Apo D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans. Mod Pathol, 21, 31–8.CrossRefGoogle ScholarPubMed
Fetsch, J.F., Laskin, W.B., and Miettinen, M. (2001). Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol, 32, 704–14.Google Scholar
Graham, R.P.D, Dry, S., Li, X., et al. (2011). Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic and genomic study. Am J Surg Pathol, 35, 1615–25.Google Scholar
Folpe, A.L. and Weiss, S.W. (2003). Ossifying fibromyxoid tumor of soft parts. Am J Surg Pathol, 27, 421–31.Google Scholar
Nishio, J., Iwaasaki, H., Ohjimi, Y., et al. (2002). Ossifying fibromyxoid tumor of soft parts: cytogenetic findings. Cancer Genet Cytogenet, 133, 124–8.Google Scholar
Martignoni, G., Pea, M., Reghellin, D., et al. (2008). PEComas: the past, the present and the future. Virchows Arch, 452, 119–32.Google Scholar
Folpe, A.L. and Kwiatkowski, D.J. (2010). Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol, 41, 115.Google Scholar
Armah, H.B. and Parwani, A.V. (2009). Perivascular epithelioid cell tumor. Arch Pathol Lab Med, 133, 648–54.Google Scholar
Wagner, A.J., Malinowska-Kolodziej, I., Morgan, J.A., et al. (2010). Clinical activity of mTOR inhibition with Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol, 28, 835–40.Google Scholar
Hornick, J.L. and Fletcher, C.D.M. (2006). PEComa: what do we know so far? Histopathology, 48, 7582.Google Scholar
Mentzel, T., Reibhauer, S., Rutten, A., et al. (2005). Cutaneous clear cell myomelanocytic tumor: a new member of the growing family of perivascular epithelioid cell tumors (PEComas). Clinicopathologic and immunohistochemical analysis of seven cases. Histopathology, 46, 498504.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×